SCHEMBL5459692

SCHEMBL5459692

Fc1cc(Nc2nc3cc(C(F)(F)F)cc(Cl)c3[nH]2)ccc1OC1=CC2=CNSN2C=C1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5448421 0.92 TEK (0.37) KDR
SCHEMBL5452397 0.91 PIM1 (0.31) KDR
SCHEMBL5766188 0.88 CBFB (0.33) KDR
SCHEMBL5458910 0.87
SCHEMBL5444068 0.83 TEK (0.37) KDR
SCHEMBL5452232 0.81 TEK (0.30) KDR
SCHEMBL5449919 0.78 KDR (0.36) KDR
SCHEMBL5765454 0.75 RIPK1 (0.39) KDR
SCHEMBL5459695 0.74 KDR (0.41) KDR
SCHEMBL5447170 0.74 RAF1 (0.33) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021456-A1 Aminobenzimidazole derivatives MERCK PATENT GMBH (DE) 2007-01-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021456-A1 Aminobenzimidazole derivatives TIE1, KDR, FLT1 KDR 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.